Clinical Trial Update: Does Cyclosporine ImpRove Clinical oUtcome in ST Elevation Myocardial Infarction Patients at 3 Years of Follow-up. CIRCUS II Study [Phase 3]

View source ↗

Summary

The update concerns the Phase 3 CIRCUS II trial evaluating cyclosporine for improving outcomes in patients with ST-elevation myocardial infarction, with 3-year …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: ST Elevation Acute Myocardial Infarction | Phase 3 | Status: COMPLETED